Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Surmodics Inc (SRDX)

Surmodics Inc (SRDX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 532,776
  • Shares Outstanding, K 13,488
  • Annual Sales, $ 81,340 K
  • Annual Income, $ -4,460 K
  • 60-Month Beta 1.24
  • Price/Sales 6.78
  • Price/Cash Flow 41.47
  • Price/Book 4.78

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate 0.05
  • Number of Estimates 1
  • High Estimate 0.05
  • Low Estimate 0.05
  • Prior Year 0.27
  • Growth Rate Est. (year over year) -81.48%

Price Performance

See More
Period Period Low Period High Performance
1-Month
38.64 +0.96%
on 06/26/19
44.87 -13.06%
on 06/20/19
-3.43 (-8.08%)
since 05/24/19
3-Month
38.06 +2.50%
on 05/20/19
48.02 -18.76%
on 04/09/19
-2.69 (-6.45%)
since 03/26/19
52-Week
38.06 +2.50%
on 05/20/19
82.35 -52.63%
on 09/04/18
-15.79 (-28.81%)
since 06/26/18

Most Recent Stories

More News
Here's Why You Should Hold on to Surmodics (SRDX) Stock Now

Surmodics (SRDX) is gaining from consistent growth In Vitro Diagnostics (IVD) unit and persistent efforts to boost R&D functionalities.

OXFD : 13.42 (-0.81%)
SRDX : 39.01 (-1.24%)
HAE : 116.63 (+0.03%)
CSII : 41.61 (-0.07%)
Watch for Surmodics Inc to Potentially Rebound After Falling 6.99% Yesterday

Surmodics Inc (NASDAQ:SRDX) traded in a range yesterday that spanned from a low of $39.80 to a high of $40.98. Yesterday, the shares fell 7.0%, which took the trading range below the 3-day low of $39.97...

SRDX : 39.01 (-1.24%)
Zacks.com featured highlights include: LexinFintech, Veeco, Helen of Troy, Surmodics and Herman Miller

Zacks.com featured highlights include: LexinFintech, Veeco, Helen of Troy, Surmodics and Herman Miller

VECO : 11.31 (+3.38%)
SRDX : 39.01 (-1.24%)
HELE : 131.33 (-1.14%)
LX : 11.35 (+0.89%)
MLHR : 37.83 (+1.94%)
Zacks.com featured highlights include: LexinFintech, Herman Miller, Interactive Brokers, ConnectOne and Surmodics

Zacks.com featured highlights include: LexinFintech, Herman Miller, Interactive Brokers, ConnectOne and Surmodics

CNOB : 21.99 (+0.92%)
IBKR : 52.35 (-0.98%)
SRDX : 39.01 (-1.24%)
LX : 11.35 (+0.89%)
MLHR : 37.83 (+1.94%)
5 Stocks to Keep an Eye on as Analysts Initiate Coverage

More analyst coverage over the last few weeks might lead to solid price appreciation for these stocks.

CNOB : 21.99 (+0.92%)
IBKR : 52.35 (-0.98%)
SRDX : 39.01 (-1.24%)
LX : 11.35 (+0.89%)
MLHR : 37.83 (+1.94%)
Report: Exploring Fundamental Drivers Behind Helen of Troy, Koppers, Central Garden & Pet, and Surmodics -- New Horizons, Emerging Trends, and Upcoming Developments

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Helen of Troy Limited (NASDAQ:HELE),...

SRDX : 39.01 (-1.24%)
HELE : 131.33 (-1.14%)
CENT : 26.67 (-0.82%)
CENTA : 24.00 (-1.23%)
KOP : 26.96 (+2.04%)
Surmodics (SRDX) Q2 Earnings and Revenues Beat Estimates

Surmodics (SRDX) consistently gains traction from its core Medical Devices unit, which witnesses a substantial contribution from the SurVeil pact with Abbott.

ABT : 82.96 (-1.52%)
SYK : 202.37 (-0.70%)
SRDX : 39.01 (-1.24%)
CNMD : 83.63 (-1.70%)
Surmodics Reports Second Quarter Fiscal 2019 Results

Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced results for its fiscal 2019 second quarter...

SRDX : 39.01 (-1.24%)
Earnings Preview: SurModics (SRDX) Q2 Earnings Expected to Decline

SurModics (SRDX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

SRDX : 39.01 (-1.24%)
Surmodics to Webcast Second Quarter Fiscal 2019 Earnings Conference Call on May 1

Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that it will host a live webcast of its...

SRDX : 39.01 (-1.24%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Good. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade SRDX with:

Business Summary

SurModics, Inc. is a leading provider of surface modification technologies in the areas of biocompatibility, site specific drug delivery, biological cell encapsulation, and medical diagnostics. SurModics partners with the world's foremost medical device, pharmaceutical and life science companies to bring...

See More

Key Turning Points

2nd Resistance Point 41.27
1st Resistance Point 40.14
Last Price 39.01
1st Support Level 38.26
2nd Support Level 37.51

See More

52-Week High 82.35
Fibonacci 61.8% 65.43
Fibonacci 50% 60.21
Fibonacci 38.2% 54.98
Last Price 39.01
52-Week Low 38.06

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar